Difluprednate Emulsion
Product Images NDC 62332-750

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Difluprednate (NDC 62332-750). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Difluprednate-bottle-label (Difluprednate Bottle Label)

Label for Difluprednate Ophthalmic Emulsion 0.05%, sterile, 5 mL, by Alembic Pharmaceuticals Inc. The label includes the NDC 62332-750-05, active ingredient concentration, and manufacturer information. It notes prescription use, lot and expiration placeholders, and features a barcode and Alembic logo.*

FDA Label Image

Difluprednate-carton (Difluprednate Carton)

Difluprednate Ophthalmic Emulsion 0.05% sterile eye drops packaging label. The 5 mL bottle is for topical eye use only, labeled as Rx only. Manufactured by Alembic Pharmaceuticals Inc. in the USA and Alembic Pharmaceuticals Limited in India. The label includes active and inactive ingredient information, storage instructions, and a barcode.*

FDA Label Image

Difluprednate-figure-1 (Difluprednate Figure 1)

A bar chart comparing the percentage of subjects with anterior chamber cells clearing (cell count = 0) on Days 8 and 15 between Difluprednate ophthalmic emulsion (0.5 mg/mL) given QID and placebo groups. The chart shows higher percentages for Difluprednate on both days, with statistical significance indicated for these differences.*

FDA Label Image

Difluprednate-figure-2 (Difluprednate Figure 2)

A bar graph titled 'Percent of Subjects who were Pain Free' comparing Difluprednate ophthalmic emulsion 0.5 mg/mL QID (n=107) and placebo (n=220) on Days 3, 8, and 15. The graph shows higher pain-free percentages for Difluprednate (45%, 58%, and 63%) than placebo (25%, 27%, and 35%) at all time points, with statistically significant differences indicated.*

FDA Label Image

Difluprednate-structure (Difluprednate Structure)

Chemical structure of difluprednate, the active ingredient in Difluprednate ophthalmic emulsion 0.5 mg/mL by Alembic Pharmaceuticals Inc. The diagram depicts the molecular formula with labeled functional groups and bonds in a steroid backbone.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.